SEC Filing Details
Document Details
Form
Filing Date
Feb 12, 2025
Document Date
Feb 12, 2025
Form Description
SCHEDULE 13G/A - Description
Company
Denali Therapeutics
Issuer
Denali Therapeutics Inc.